SCHEMBL1389930

SCHEMBL1389930

Cc1cc(F)ccc1[C@H](C/C(=N\O)c1ccc(=O)n(C)c1)c1ccc(-c2ccc(S(N)(=O)=O)cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 5/20 0.40
CHRNA7 P36544 4/20 0.35
CA1 P00915 11/20 0.34
CA2 P00918 11/20 0.34
CA9 Q16790 10/20 0.34
CA12 O43570 7/20 0.34
CA14 Q9ULX7 4/20 0.34
CA4 P22748 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1390245 1.00 GPBAR1 (0.40) GPBAR1CHRNA7CA1CA2CA9
SCHEMBL1390246 1.00 GPBAR1 (0.40) GPBAR1CHRNA7CA1CA2CA9
SCHEMBL1389860 1.00 GPBAR1 (0.40) GPBAR1CHRNA7CA1CA2CA9
SCHEMBL1389857 1.00 GPBAR1 (0.40) GPBAR1CHRNA7CA1CA2CA9
SCHEMBL1389932 1.00 GPBAR1 (0.40) GPBAR1CHRNA7CA1CA2CA9
SCHEMBL10241381 0.90 GPBAR1 (0.40) GPBAR1CHRNA7CA1CA2CA9
SCHEMBL370177 0.90 GPBAR1 (0.40) GPBAR1CHRNA7CA1CA2CA9
SCHEMBL10241383 0.90 GPBAR1 (0.40) GPBAR1CHRNA7CA1CA2CA9
SCHEMBL1390699 0.90 GPBAR1 (0.40) GPBAR1CHRNA7CA1CA2CA9
SCHEMBL368296 0.90 GPBAR1 (0.42) GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885CHRNA7 2081/4885CA1 4249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.